The Vent Multiplexor is a patent-pending emergency co-ventilation device intended to provide individualized temporary rescue mechanical ventilation during the COVID-19 pandemic. Developed in collaboration with Yale-New Haven Hospital and granted Emergency Use Authorization by the FDA on April 15, 2020, the Vent Multiplexor has the potential to help reduce the clinical need for ventilators during the COVID-19 pandemic, as it permits the emergency sharing of ventilators between two patients who are not equally matched, by delivering individualized tidal volumes, while also providing critical validation data on the quality of patient matching using existing “T-connector” and similar ventilator splitting technologies, a potentially revolutionary paradigm shift in the delivery of pandemic emergency respiratory care.
The Vent Multiplexor is a patent-pending device designed to provide individualized emergency crisis care for two adult patients requiring mechanical ventilation for respiratory failure when limited to a single mechanical ventilator. The Vent Multiplexor was developed in Connecticut by Vent Multiplexor LLC in collaboration with Yale New Haven Hospital and is intended to provide temporary emergency rescue co-ventilation until an additional ventilator is available to resume single mechanical ventilation or as soon as respiratory recovery is attained in either patient.